Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Drug Carriers MeSH Descriptor Data 2026


MeSH Heading
Drug Carriers
Tree Number(s)
D26.255.260
E02.319.300.380
Unique ID
D004337
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004337
Annotation
coord with specific drug
Scope Note
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
Registry Numbers
0
NLM Classification #
QV 785
Previous Indexing
Delayed-Action Preparations (1966-1987)
Drugs (1966-1987)
See Also
Magnetic Iron Oxide Nanoparticles
Public MeSH Note
88
History Note
88
Date Introduced
1988/01/01
Last Updated
2020/06/17
Drug Carriers Preferred
page delivered in 0.132s